Back to search

Article

Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral Strategy

2025-11-15

Abstract excerpt

Although therapeutic drugs targeting gasdermin (GSDM)-mediated pyroptosis have made remarkable progress in treating various diseases, their potential for antiviral therapy remains largely unexplored. Inspired by the autoinhibitory mechanism of GSDM proteins and the clinical success of mRNA vaccines, herein we propose a concept of viral protease-initiated pyroptosis (VIP) mRNA therapy as a universal antiviral strat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8358c34-e57d-53c0-a65c-dcaa32dd0abb
DOI
10.1101/2025.11.14.688189
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Viral protease-Initiated Pyroptosis Activator mRNA therapy as a Universal Antiviral StrategyDOI 10.1101/2025.11.14.688189
Select a neighboring publication to make it the new centre.